The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...
In a new study, scientists discovered two FDA-approved cancer drugs that could also be effective at combatting one well-known ...
Last year, the U.S. Food and Drug Administration banned the sale of compounded weight loss drugs, which are often much ...
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...
A new generation of companies is eyeing the existing, sizeable hair loss market, hoping that better formulations and new ...
Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about ...
The Food and Drug Administration is investigating infant botulism cases that may be tied to two batches of infant formulas.
The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes ...
Arrowhead Pharmaceuticals (ARWR) stock gains as the company wins FDA nod for lead drug Redemplo for a rare condition. Read more here.
The United States Food and Drug Administration (FDA) has removed "black box" warnings on many hormone treatments used to ...
FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results